scholarly article | Q13442814 |
P50 | author | John A Cidlowski | Q62823441 |
Tiffany N Seagroves | Q73088022 | ||
Carlos Perez Kerkvliet | Q89507017 | ||
Kathryn L Schwertfeger | Q91244526 | ||
Carol A Lange | Q101563783 | ||
Julie H. Ostrander | Q117074347 | ||
Tarah M. Regan Anderson | Q117074442 | ||
P2093 | author name string | Yan Peng | |
Ganesh V Raj | |||
Shihong Ma | |||
Raisa I Krutilina | |||
Taylor M Helle | |||
P2860 | cites work | Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | Q24307473 |
Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin | Q24318315 | ||
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor | Q24564124 | ||
Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer | Q26772892 | ||
Anoikis molecular pathways and its role in cancer progression | Q26852158 | ||
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells | Q44783902 | ||
Hypoxia-inducible factor 1 mediates intermittent hypoxia-induced migration of human breast cancer MDA-MB-231 cells | Q47109212 | ||
NCCN Guidelines Insights: Breast Cancer, Version 1.2017. | Q47579286 | ||
EMT, cell plasticity and metastasis. | Q53666394 | ||
Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma. | Q54481449 | ||
Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and AH receptor pathway gene expression in the developing mouse mammary gland | Q77409978 | ||
Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer | Q81100723 | ||
Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients | Q81682235 | ||
Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis | Q83995323 | ||
A perspective on cancer cell metastasis | Q28307891 | ||
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies | Q29617680 | ||
2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity | Q29618527 | ||
Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells | Q33283847 | ||
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs | Q33568421 | ||
PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival | Q33644326 | ||
Brk/PTK6 signaling in normal and cancer cell models | Q33690176 | ||
Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor | Q33804702 | ||
HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion | Q34036107 | ||
Endogenous kynurenines as targets for drug discovery and development | Q34156448 | ||
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells | Q34173535 | ||
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors | Q34227580 | ||
Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression | Q34304234 | ||
Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression. | Q34912116 | ||
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer | Q34989075 | ||
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes | Q35558105 | ||
Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling | Q35598838 | ||
Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells | Q35642132 | ||
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR | Q35888553 | ||
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. | Q36054418 | ||
PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation. | Q36211459 | ||
Nuclear hormone receptor degradation and gene transcription: an update | Q36219014 | ||
A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. | Q36244860 | ||
Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer | Q36445441 | ||
Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition | Q36677706 | ||
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer | Q36679783 | ||
Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer | Q36693131 | ||
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer. | Q37056571 | ||
Anoikis resistance and tumor metastasis | Q37199998 | ||
Activation of the aryl hydrocarbon receptor during different critical windows in pregnancy alters mammary epithelial cell proliferation and differentiation | Q37303870 | ||
Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage. | Q37316549 | ||
Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Krüppel-like factor 5 in triple-negative breast cancer | Q37706950 | ||
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors | Q40182922 | ||
Prognostic and predictive factors in breast cancer by immunohistochemical analysis. | Q40866567 | ||
Progesterone induces adult mammary stem cell expansion | Q42471079 | ||
Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer | Q43252129 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 11 | |
P921 | main subject | paclitaxel | Q423762 |
P304 | page(s) | 1761-1772 | |
P577 | publication date | 2018-07-10 | |
P1433 | published in | Molecular Cancer Research | Q2751014 |
P1476 | title | Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis | |
P478 | volume | 16 |
Q94481933 | Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer |
Q90643576 | Protein tyrosine kinase 6 signaling in prostate cancer |
Q90630036 | Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide |
Search more.